Shinsaku Yamane

This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Ono Pharmaceutical Co., Ltd., Ono Pharmaceuticals Co., Ltd.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinsaku Yamane. Retrieved from https://idiyas.com/inventor/shinsaku-yamane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 90.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 44(Granted Patents)

Company Filing History:

9 out of 575

Ono Pharmaceutical Co., Ltd.

patents

2 out of 22

Ono Pharmaceuticals Co., Ltd.

patents

Years Active: 2013-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12201603 - Bicyclic compound and use thereof for medical purposes (2025-01-21),

2. 11617733 - Bicyclic compound and use thereof for medical purposes (2023-04-04),

3. 10940134 - Bicyclic compound and use thereof for medical purposes (2021-03-09),

4. 10385045 - Compound having EP2 agonist activity (2019-08-20),

5. 10201520 - Bicyclic compound and use thereof for medical purposes (2019-02-12),

6. 9890146 - Compound having selective EP2 agonist activity (2018-02-13),

7. 9889114 - Bicyclic compound and use thereof for medical purposes (2018-02-13),

8. 9388157 - Bicyclic compound and use thereof for medical purposes (2016-07-12),

9. 9150537 - Bicyclic compound and use thereof for medical purposes (2015-10-06),

10. 8962868 - Bicyclic compound and use thereof for medical purposes (2015-02-24),

11. 8614340 - Bicyclic compound and use thereof for medical purposes (2013-12-24),

Title: Shinsaku Yamane: Innovator in Medical Compounds

Introduction

Shinsaku Yamane is a prominent inventor based in Osaka, Japan, known for his significant contributions to the field of medical compounds. With a total of 11 patents to his name, he has made remarkable advancements in the treatment of ocular conditions, particularly glaucoma.

Latest Patents

Among his latest patents is a bicyclic compound that demonstrates strong and sustained intraocular pressure-lowering activity. This compound, represented by a specific general formula, has been shown to have no adverse side effects on the eyes, such as ocular stimulation or increased aqueous humor protein levels. Its high safety profile positions it as an excellent candidate for preventing and treating glaucoma.

Career Highlights

Shinsaku Yamane has worked with notable companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His work has focused on developing innovative solutions that address critical medical needs.

Collaborations

Throughout his career, Yamane has collaborated with esteemed colleagues, including Kousuke Tani and Tohru Kambe, contributing to the advancement of medical research and innovation.

Conclusion

Shinsaku Yamane's work in developing bicyclic compounds for medical purposes highlights his dedication to improving patient outcomes in ocular health. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.